Skip to main content

Table 1 Patient clinical characteristics

From: Elevated troponin and myocardial infarction in the intensive care unit: a prospective study

 

Total (n = 115)

MI (n = 24)

No MI (n = 91)

P value

Age (years; mean ± SD)

64.1 ± 17.2

62.8 ± 18.3

64.4 ± 17.0

0.69

Sex (n; % female)

61 (53.0)

13 (54.2)

48 (52.7)

1.00

APACHE II score (mean ± SD)

21.9 ± 9.8

26.3 ± 10.4

20.7 ± 9.3

0.01

Medical (n [%])

83 (72.2)

20 (83.3)

63 (69.2)

0.21

Epidural (n [%])

12 (10.4)

0 (0.0)

12 (13.2)

0.07

Past medical history (n [%])

    

   Smoker

35 (30.4)

5 (20.8)

30 (33.0)

0.32

   Hypertension

59 (51.3)

14 (58.3)

45 (49.5)

0.50

   Diabetes (oral agent)

9 (7.8)

3 (12.5)

6 (6.6)

0.39

   Diabetes (insulin)

17 (14.8)

10 (41.7)

7 (7.7)

<0.001

   Hypercholesterolemia

14 (12.2)

2 (8.3)

12 (13.2)

0.73

   Angina

15 (13.0)

3 (12.5)

12 (13.2)

1.00

   Myocardial infarction

25 (21.7)

9 (37.5)

16 (17.6)

0.05

   Congestive heart failure

14 (12.2)

5 (20.8)

9 (9.9)

0.17

   Peripheral vascular disease

10 (8.7)

7 (29.2)

3 (3.3)

<0.001

   Transient ischemic attack

4 (3.5)

2 (8.3)

2 (2.2)

0.19

   Stroke

8 (7.0)

3 (12.5)

5 (5.5)

0.36

Baseline life support interventions (n [%])

    

   Ventilation

    

Invasive mechanical ventilation

67 (58.3)

16 (66.7)

51 (56.0)

0.49

Noninvasive mechanical ventilation

5 (4.3)

2 (8.3)

3 (3.3)

0.28

   Inotropes and vasopressors

    

Epinephrine

2 (1.7)

1 (4.2)

1 (1.1)

0.38

Dopamine

10 (8.7)

3 (12.5)

7 (7.7)

0.43

Norepinephrine

19 (16.5)

5 (20.8)

14 (15.4)

0.54

Dobutamine

4 (3.5)

2 (8.3)

2 (2.2)

0.19

Phenylephrine

18 (15.7)

9 (37.5)

9 (9.9)

0.003

Vasopressin

5 (4.3)

3 (12.5)

2 (2.2)

0.06

   Hemodialysis

    

Intermittent dialysis

14 (12.2)

4 (16.7)

10 (11.0)

0.49

Continuous renal replacement therapy

0 (0.0)

0 (0.0)

0 (0.0)

-

  1. APACHE, Acute Physiology and Chronic Health Evaluation; MI, myocardial infarction; SD, standard deviation.